PHAT Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | Henderson Molly | officer: CFO and CBO | 76,015 | S-Sale | D | 2,032 | 8.53 | 17,334.79 |
| 2023-03-01 | Curran Terrie | director, officer: President and Chief Executive | 175,371 | S-Sale | D | 1,436 | 8.54 | 12,265.02 |
| 2023-02-13 | Parikh Asit | director | 22,500 | P-Purchase | A | 5,000 | 7.73 | 38,660.00 |
| 2023-01-20 | Curran Terrie | director, officer: President and Chief Executive | 176,807 | S-Sale | D | 5,821 | 8.20 | 47,729.29 |
| 2023-01-19 | Curran Terrie | director, officer: President and Chief Executive | 162,500 | A-Award | D | 162,500 | 8.35 | 1,356,875.00 |
| 2023-01-19 | Curran Terrie | director, officer: President and Chief Executive | 182,628 | A-Award | A | 97,500 | 0.00 | 0.00 |
| 2023-01-19 | Nabulsi Azmi | officer: Chief Operating Officer | 75,000 | A-Award | A | 75,000 | 8.35 | 626,250.00 |
| 2023-01-19 | Nabulsi Azmi | officer: Chief Operating Officer | 89,567 | A-Award | A | 45,000 | 0.00 | 0.00 |
| 2023-01-19 | Henderson Molly | officer: CFO and CBO | 55,000 | A-Award | A | 55,000 | 8.35 | 459,250.00 |
| 2023-01-19 | Henderson Molly | officer: CFO and CBO | 78,047 | A-Award | A | 33,000 | 0.00 | 0.00 |
| 2023-01-12 | Parikh Asit | director | 17,500 | P-Purchase | A | 5,000 | 7.00 | 35,000.00 |
| 2022-11-21 | Henderson Molly | officer: CFO and CBO | 43,341 | S-Sale | D | 2,159 | 9.60 | 20,726.40 |
| 2022-11-21 | Curran Terrie | director, officer: President and Chief Executive | 83,720 | S-Sale | D | 1,526 | 9.60 | 14,649.60 |
| 2022-09-22 | Topper James N | director, 10 percent owner | 20,000 | A-Award | A | 20,000 | 10.02 | 200,400.00 |
| 2022-09-01 | Nabulsi Azmi | officer: Chief Operating Officer | 41,971 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-09-01 | Curran Terrie | director, officer: President and Chief Executive | 85,246 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-09-01 | Henderson Molly | officer: CFO and CBO | 45,500 | A-Award | A | 7,500 | 0.00 | 0.00 |
| 2022-05-25 | COLA MICHAEL F | director | 15,000 | A-Award | A | 15,000 | 7.40 | 111,000.00 |
| 2022-05-25 | Stenhouse Mark | director | 15,000 | A-Award | A | 15,000 | 7.40 | 111,000.00 |
| 2022-05-25 | FIELDS HEIDI | director | 15,000 | A-Award | A | 15,000 | 7.40 | 111,000.00 |
| 2022-05-25 | Socks David A | director | 15,000 | A-Award | A | 15,000 | 7.40 | 111,000.00 |
| 2022-05-25 | KARBE FRANK | director | 10,000 | A-Award | A | 10,000 | 7.40 | 74,000.00 |
| 2022-05-25 | Parikh Asit | director | 15,000 | A-Award | A | 15,000 | 7.40 | 111,000.00 |
| 2022-05-19 | Nabulsi Azmi | officer: Chief Operating Officer | 33,378 | A-Award | A | 12,000 | 0.00 | 0.00 |
| 2022-05-19 | Curran Terrie | director, officer: President and Chief Executive | 76,595 | A-Award | A | 12,000 | 0.00 | 0.00 |
| 2022-05-19 | Henderson Molly | officer: CFO and CBO | 38,000 | A-Award | A | 12,000 | 0.00 | 0.00 |
| 2022-05-16 | Nabulsi Azmi | officer: Chief Operating Officer | 785,700 | P-Purchase | A | 20,000 | 8.16 | 163,288.00 |
| 2022-05-13 | Curran Terrie | director, officer: President and Chief Executive | 64,595 | P-Purchase | A | 20,500 | 7.41 | 151,835.30 |
| 2022-05-13 | Henderson Molly | officer: CFO and CBO | 26,000 | P-Purchase | A | 6,000 | 0.00 | 0.00 |
| 2022-05-12 | Parikh Asit | director | 12,500 | P-Purchase | A | 12,500 | 8.00 | 100,000.00 |
| 2022-04-25 | KARBE FRANK | director | 20,000 | A-Award | A | 20,000 | 13.61 | 272,200.00 |
| 2022-04-05 | Henderson Molly | officer: CFO and CBO | 100,000 | A-Award | A | 100,000 | 15.08 | 1,508,000.00 |
| 2022-04-05 | Henderson Molly | officer: CFO and CBO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 0 | X-InTheMoney | D | 7,359,304 | 0.00 | 0.00 |
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 7,459,286 | S-Sale | D | 18 | 19.00 | 342.00 |
| 2022-03-14 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 7,459,304 | X-InTheMoney | A | 7,359,304 | 0.00 | 0.00 |
| 2022-01-19 | Nabulsi Azmi | officer: Chief Operating Officer | 97,500 | A-Award | A | 97,500 | 15.21 | 1,482,975.00 |
| 2022-01-19 | Nabulsi Azmi | officer: Chief Operating Officer | 21,378 | A-Award | A | 19,500 | 0.00 | 0.00 |
| 2022-01-19 | Curran Terrie | director, officer: President and Chief Executive | 206,250 | A-Award | A | 206,250 | 15.21 | 3,137,062.50 |
| 2022-01-19 | Curran Terrie | director, officer: President and Chief Executive | 44,095 | A-Award | A | 41,250 | 0.00 | 0.00 |
| 2022-01-19 | Guzzo Anthony J. | officer: VP, Chief Accounting Officer | 30,000 | A-Award | A | 30,000 | 15.21 | 456,300.00 |
| 2022-01-19 | Guzzo Anthony J. | officer: VP, Chief Accounting Officer | 8,399 | A-Award | A | 6,000 | 0.00 | 0.00 |
| 2021-11-04 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 7,359,304 | X-InTheMoney | D | 228,696 | 0.00 | 0.00 |
| 2021-11-04 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 100,000 | S-Sale | D | 1,000,000 | 20.85 | 20,850,000.00 |
| 2021-11-04 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1,100,000 | S-Sale | D | 1 | 19.00 | 19.00 |
| 2021-11-04 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1,100,001 | X-InTheMoney | A | 228,696 | 0.00 | 0.00 |
| 2021-10-08 | Socks David A | director | 1,211,346 | S-Sale | D | 2,529 | 32.05 | 81,051.92 |
| 2021-10-07 | Socks David A | director | 1,213,875 | S-Sale | D | 15,471 | 32.66 | 505,343.20 |
| 2021-09-22 | Socks David A | director | 1,229,346 | S-Sale | D | 4,100 | 32.06 | 131,446.00 |
| 2021-09-21 | Socks David A | director | 1,233,446 | S-Sale | D | 324 | 33.31 | 10,791.08 |
| 2021-09-21 | Socks David A | director | 1,233,770 | S-Sale | D | 13,576 | 32.79 | 445,113.60 |
| 2021-08-16 | Socks David A | director | 1,261,137 | S-Sale | D | 4,209 | 30.47 | 128,249.91 |
| 2021-08-16 | Socks David A | director | 1,247,346 | S-Sale | D | 13,791 | 31.49 | 434,288.24 |
| 2021-07-13 | Parikh Asit | director | 7,500 | A-Award | A | 7,500 | 34.05 | 255,375.00 |
| 2021-07-07 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 871,305 | S-Sale | D | 2,609 | 35.05 | 91,445.45 |
| 2021-07-02 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 873,914 | S-Sale | D | 100 | 35.01 | 3,501.00 |
| 2021-07-01 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 874,014 | S-Sale | D | 8,226 | 35.16 | 289,226.16 |
| 2021-06-29 | Socks David A | director | 1,260,945 | S-Sale | D | 13,960 | 34.00 | 474,656.75 |
| 2021-06-28 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 882,240 | S-Sale | D | 370 | 35.08 | 12,979.60 |
| 2021-06-28 | Socks David A | director | 1,275,061 | S-Sale | D | 25,884 | 34.07 | 881,810.94 |
| 2021-06-28 | Socks David A | director | 1,274,905 | S-Sale | D | 156 | 35.09 | 5,473.56 |
| 2021-06-25 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 883,860 | S-Sale | D | 22,881 | 35.46 | 811,360.26 |
| 2021-06-25 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 882,610 | S-Sale | D | 1,250 | 36.07 | 45,087.50 |
| 2021-06-24 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 906,741 | S-Sale | D | 10,848 | 35.14 | 381,198.72 |
| 2021-06-23 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 917,589 | S-Sale | D | 200 | 35.00 | 7,000.00 |
| 2021-06-22 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 917,789 | S-Sale | D | 100 | 35.00 | 3,500.00 |
| 2021-06-21 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 917,889 | S-Sale | D | 9,294 | 35.31 | 328,171.14 |
| 2021-06-18 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 927,183 | S-Sale | D | 5,398 | 35.13 | 189,631.74 |
| 2021-06-17 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 932,581 | S-Sale | D | 3,305 | 35.08 | 115,939.40 |
| 2021-06-14 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 935,886 | S-Sale | D | 2,826 | 35.06 | 99,079.56 |
| 2021-06-10 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 938,712 | S-Sale | D | 2,102 | 35.14 | 73,864.28 |
| 2021-06-09 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 940,814 | S-Sale | D | 1,191 | 35.28 | 42,018.48 |
| 2021-06-08 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 942,005 | S-Sale | D | 100 | 35.00 | 3,500.00 |
| 2021-06-07 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 942,105 | S-Sale | D | 2,264 | 35.05 | 79,353.20 |
| 2021-06-02 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 944,369 | S-Sale | D | 4,300 | 35.18 | 151,274.00 |
| 2021-06-01 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 948,669 | S-Sale | D | 3,967 | 36.20 | 143,605.40 |
| 2021-06-01 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 952,636 | S-Sale | D | 7,244 | 35.55 | 257,524.20 |
| 2021-05-28 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 959,880 | S-Sale | D | 2,104 | 37.55 | 79,005.20 |
| 2021-05-28 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 961,984 | S-Sale | D | 2,668 | 36.40 | 97,115.20 |
| 2021-05-28 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 964,652 | S-Sale | D | 4,133 | 35.37 | 146,184.21 |
| 2021-05-27 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 968,785 | S-Sale | D | 2,279 | 37.55 | 85,576.45 |
| 2021-05-27 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 971,064 | S-Sale | D | 6,174 | 36.99 | 228,376.26 |
| 2021-05-26 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 982,127 | S-Sale | D | 7,469 | 36.45 | 272,245.05 |
| 2021-05-26 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 977,238 | S-Sale | D | 4,889 | 36.92 | 180,501.88 |
| 2021-05-25 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 990,144 | S-Sale | D | 10,399 | 36.16 | 376,027.84 |
| 2021-05-25 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 989,596 | S-Sale | D | 548 | 36.59 | 20,051.32 |
| 2021-05-24 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1,000,543 | S-Sale | D | 1,683 | 36.10 | 60,756.30 |
| 2021-05-24 | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1,002,226 | S-Sale | D | 8,911 | 35.58 | 317,053.38 |
| 2021-05-21 | Parikh Asit | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 | |
| 2021-05-21 | Yamada Tadataka | director | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 |
| 2021-05-21 | COLA MICHAEL F | director | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 |
| 2021-05-21 | Stenhouse Mark | director | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 |
| 2021-05-21 | Socks David A | director | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 |
| 2021-05-21 | FIELDS HEIDI | director | 12,500 | A-Award | A | 12,500 | 35.49 | 443,625.00 |
| 2021-05-21 | TAKEDA PHARMACEUTICAL CO LTD | 1,011,137 | S-Sale | D | 11,648 | 35.74 | 416,299.52 | |
| 2021-05-20 | Socks David A | director | 1,301,250 | S-Sale | D | 2,278 | 34.93 | 79,579.65 |
| 2021-05-20 | Socks David A | director | 1,300,945 | S-Sale | D | 305 | 35.27 | 10,756.19 |
| 2021-05-20 | Socks David A | director | 1,303,528 | S-Sale | D | 899 | 33.76 | 30,350.78 |
| 2021-05-20 | TAKEDA PHARMACEUTICAL CO LTD | 1,022,785 | S-Sale | D | 7,098 | 35.10 | 249,139.80 | |
| 2021-05-19 | Socks David A | director | 1,323,676 | S-Sale | D | 17,269 | 31.96 | 551,842.98 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.